Old Web
English
Sign In
Acemap
>
authorDetail
>
Dennis Wagner
Dennis Wagner
AstraZeneca
Chronic lymphocytic leukemia
Medicine
Physical therapy
Internal medicine
overall survival
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Characterization of Bruton Tyrosine Kinase Inhibitor (BTKi)-Related Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)
2021
Blood
John F. Seymour
John C. Byrd
Peter Hillmen
Paolo Ghia
Arnon P. Kater
Asher Chanan-Khan
Richard R. Furman
Susan OBrien
Jennifer R. Brown
Anthony R. Mato
Stephan Stilgenbauer
Nataliya Kuptsova-Clarkson
Paulo Miranda
Dennis Wagner
Kara Higgins
Sophia Sohoni
Wojciech Jurczak
Show All
Source
Cite
Save
Citations (0)
Retrospective cohort study of real-world treatment patterns and overall survival in patients with chronic lymphocytic leukemia (CLL) diagnosed between 2010 to 2017 in Ontario, Canada.
2020
Journal of Clinical Oncology
Shazia Hassan
M. Hurry
Soo Jin Seung
R Walton
Ashlie Elnoursi
Krystin Scheider
Jonathan Edwin
Dennis Wagner
Andrew Aw
Show All
Source
Cite
Save
Citations (0)
1